Source comparison
CJC-1295 Variants: DAC vs No-DAC Pharmacokinetics
CJC-1295 with DAC 6–8 days 24–40 days (>95% elimination) Once weekly Up to 30–40 days via LC-MS/MS Yes. Covalent maleimide-thiol bond CJC-1295 No-DAC (Modified GRF 1-29) ~30 minutes 2–4 hours 2–3 times daily 4–6 hours post-injection No. Rapid renal filtration
This comparison does not assign a generated winner or score.
- CJC-1295 with DAC
- 6–8 days
- 24–40 days (>95% elimination)
- Once weekly
- Up to 30–40 days via LC-MS/MS
- Yes. Covalent maleimide-thiol bond
- CJC-1295 No-DAC (Modified GRF 1-29)
- ~30 minutes
- 2–4 hours
- 2–3 times daily
- 4–6 hours post-injection
- No. Rapid renal filtration
- Professional Assessment
- The DAC modification extends half-life by over 200-fold. The two variants are not interchangeable. Study design, dosing protocols, and wash-out periods must account for the specific form used. Mislabeling or assumption of equivalence is the leading cause of protocol failure in peptide research.